会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • BISACYLOXYPROPYLCYSTEINE CONJUGATES AND THE USE THEREOF
    • 双异丙氧基丙酮共轭物及其用途
    • WO2004009125A3
    • 2004-05-27
    • PCT/EP0307892
    • 2003-07-18
    • BIOTECHNOLOG FORSCHUNG GMBHMUEHLRADT PETERMORR MICHAEL
    • MUEHLRADT PETERMORR MICHAEL
    • A61K47/48
    • A61K47/60
    • The invention relates to novel lipopeptide conjugates, in which a cysteine that is double-substituted by a fatty acid is bonded by means of the carboxyl group to a highly soluble, physiologically compatible and non-immunogenic, polymeric conjugate group. The novel conjugates exhibit an excellent macrophage stimulant action and do not require additional solutizing. They can be used in a wide range of applications, in particular for stimulating macrophages, for stimulating antibody synthesis, for combating infection, as an immunostimulant, in particular in relation to tumours, for preventing and treating septicaemic shock, for wound healing and as an adjuvant for vaccines.
    • 存在其中的双脂肪酸取代的羧基基团的半胱氨酸来提出的新的脂肽缀合物一个易溶于水的和生理上耐受的和非免疫原性聚合物缀合物基团结合。 新的结合物显示非常好的巨噬细胞刺激作用,并且不需要额外的溶解。 它们本身对许多用途,特别是用于刺激巨噬细胞,刺激抗体的合成,用于抗感染防御,用于刺激免疫,特别是抗肿瘤,对于脓毒性休克的预防和治疗,用于伤口愈合,并作为疫苗的佐剂。
    • 10. 发明申请
    • LIPOPEPTIDE- AND LIPOPROTEIN-CONJUGATES AND ITS USE
    • LIPOPEPTIDE-和LIPOPROTEIN-CONJUGATES及其用途
    • WO2011080259A1
    • 2011-07-07
    • PCT/EP2010/070776
    • 2010-12-28
    • HELMHOLTZ-ZENTRUM FÜR INFEKTIONSFORSCHUNG GMBHEBENSEN, ThomasGUZMAN, CarlosMORR, MichaelTEGGE, Werner
    • EBENSEN, ThomasGUZMAN, CarlosMORR, MichaelTEGGE, Werner
    • A61K47/48A61P35/00A61P31/16A61P31/18A61P31/12A61P31/14A61P31/20
    • A61K47/646A61K47/543A61K47/60
    • The present invention relates to new lipopeptide- and lipoprotein molecules and lipopeptide- and lipoprotein-conjugates. In particular, the present invention relates to new lipopeptide- and lipoprotein molecules and lipopeptide- and lipoprotein-conjugates comprising a lipid-containing moiety representing an adjuvant moiety, a peptide or protein moiety whereby said peptide or protein moiety represents at least one antigenic structure, the antigen-moiety, and, optionally, a conjugate moiety, preferably a monodisperse polyethyleneglycol unit. Said compounds are particularly useful for therapeutic or prophylactic vaccination by mucosal or systemic administration, preferably mucosal and systemic vaccination. That is, the present invention relates in another aspect to pharmaceutical compositions comprising the compounds according to the present invention, in particular, said pharmaceutical compositions are vaccines. In addition, said pharmaceutical compositions are useful for the prophylaxis or treatment of infectious diseases, inflammatory and autoimmune diseases, cancer, allergies or for the control of fertility in human or animal populations.
    • 本发明涉及新的脂肽和脂蛋白分子和脂肽和脂蛋白共轭物。 特别地,本发明涉及新的脂肽和脂蛋白分子和脂肽和脂蛋白共轭物,其包含代表佐剂部分的脂质部分,肽或蛋白质部分,由此所述肽或蛋白质部分代表至少一种抗原结构, 抗原部分和任选的缀合物部分,优选单分散聚乙二醇单元。 所述化合物特别可用于通过粘膜或全身给药进行治疗或预防性接种,优选粘膜和全身性接种疫苗。 也就是说,本发明在另一方面涉及包含根据本发明的化合物的药物组合物,特别是所述药物组合物是疫苗。 此外,所述药物组合物可用于预防或治疗感染性疾病,炎性和自身免疫性疾病,癌症,过敏或用于控制人或动物群体的生育力。